Evaluation • Treatment • Patient Care • Procedures • Challenging Cases

Update in Clinical Cardiology will be held on October 16 – 18, 2024. You have the option to attend either online as the course is live streamed or in person in Boston, MA. All sessions will be recorded and made available to all participants to view online, at your convenience, for 60 days following the course.
 

COURSE OVERVIEW

Update in Clinical Cardiology provides comprehensive updates for state-of-the-art care and guidance to incorporate them into daily practice to optimize patient outcomes. Coverage includes: 

• Coronary Artery Disease
• Diabetes and Obesity
• Valvular Heart Disease 
• Cardiac Biomarkers
• Heart Failure (reduced and preserved ejection fraction)
• Pulmonary Hypertension
• Cardiomyopathies
• Dyslipidemia 
• Hypertension
• Atrial Fibrillation
• Supraventricular Tachycardia 
• Ventricular Arrhythmias 
• Thoracic Aortic Disease 
• Pericarditis
• Peripheral Arterial Disease 
• Renal Artery Stenosis
• Pulmonary Embolism and Venous Thromboembolism
• Cardio-oncology
• Adult Congenital Heart Disease
• Cardiac Critical Care 
• Spontaneous Coronary Artery Dissection (SCAD)
• Heart Disease in Pregnancy 
• Sports Cardiology
• Endocarditis

The faculty is assembled from the best clinician-educators at Harvard Medical School and Massachusetts General Hospital and is designed to deliver the highest quality educational experience:

• Teaching practical, effective clinical reasoning and approaches that enable you to practice state-of-the-art clinical cardiology
• Allowing ample time for participants to interact with faculty and to pose and get answers to your specific questions, including Q&A sessions and case-based panel discussions 
• Providing the latest information in an engaging manner and clinically usable context so that you have knowledge you can “take home” and immediately apply to patient care

2024 PROGRAM HIGHLIGHTS

• Management of obesity and diabetes for improved cardiovascular health outcomes
• Use of GLP-1 agonists and SGLT2-inhibitors 
• Thoracic aortic disease Guideline Writing Committee chair, Dr. Eric M. Isselbacher, presents and answers your questions about the new guidelines for diagnosis and treatment 
• New clinical trials: data findings, updates, and implications for daily practice
• Novel transcatheter and structural treatment options: important updates for the management of valvular disease
• Optimized approaches to heart failure and cardiomyopathies, including hypertrophic cardiomyopathy and cardiac amyloidosis
• Advances in electrical devices and mechanical support
• Complex coronary artery disease management in the cath lab with novel diagnostic and revascularization techniques
• Artificial intelligence (AI) and cardiovascular medicine

OPTIMIZED FOR IN-PERSON and REMOTE EDUCATION

The 2024 program has been enhanced for both in-person and distance learning. You have the option to attend either online as the course is live streamed or in person in Boston, MA. All sessions will be recorded and made available to all participants to view online, at your convenience, for 60 days following the course.